Latest Capital Raises News

Tolu Minerals has secured a $60.5 million capital raise and appointed Dr Chris Muller as CEO, setting the stage for a production restart at Tolukuma Gold Mine in the second half of 2026 alongside a major drilling program.

BMG Resources reports encouraging drill results and advances a scoping study at Abercromby, while Bullabulling drilling confirms multiple gold lodes and potential resource expansion. A recent $600,000 placement supports ongoing development.

Locate Technologies proposes a scheme to migrate its listing from ASX to NZX, enabling continuation of its Bitcoin Treasury Strategy without ASX restrictions. The move aims to broaden investor base and enhance shareholder value.

Tombador Iron Limited is set to transform into Atomic Eagle Limited through its acquisition of GoviEx Uranium Inc, creating a new ASX-listed uranium explorer focused on Africa’s Muntanga Project. A capital raise of up to A$10 million will underpin this strategic pivot.

Complii FinTech Solutions reported a 4.9% year-on-year increase in annual recurring revenue, progressed a major CRM system upgrade, and secured a $1.217 million R&D rebate in Q1 FY26, while managing cash flow pressures.

DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.

Atlantic Lithium has finalized revised fiscal terms with the Ghanaian government for its Ewoyaa Lithium Project and awaits parliamentary ratification, while reporting strong exploration results in Côte d’Ivoire and securing significant funding agreements.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

Zuleika Gold advances its Plutonic Mine litigation with a trial delay to early 2026, while gearing up for exploration drilling and bolstering its finances with new funding.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Adavale Resources has reported significant gold mineralisation extending beyond current estimates at its London Victoria Gold Mine, alongside securing $3.1 million in funding and appointing David Ward as Managing Director.